PCM
MRK icon

Palouse Capital Management’s Merck MRK Stock Holding History

Palouse Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$10.5K – 162
2025
Q4 		$10.5K Buy
+100
New +$9.39K 0.01% 137
2022
Q2 		– Sell
-39,517
Closed -$3.24M – 92
2022
Q1 		$3.24M Buy
39,517
+56
+0.1% +$4.42K 1.43% 28
2021
Q4 		$3.02M Sell
39,461
-685
-2% -$54.6K 1.29% 34
2021
Q3 		$3.02M Sell
40,146
-1,052
-3% -$80K 1.34% 31
2021
Q2 		$3.2M Buy
41,198
+2,648
+7% +$197K 1.4% 29
2021
Q1 		$2.84M Buy
+38,550
New +$2.84M 1.25% 37

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Palouse Capital Management's MRK Position: Q1 2026 in Review

Palouse Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 100 shares — an estimated $10.5K sold.

Palouse Capital Management first reported a position in MRK in Q1 2021 and held it in 6 quarters. The position peaked at $3.24M in Q1 2022. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Palouse Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Palouse Capital Management sold 100 Merck shares in Q1 2026, an estimated $10.5K.
  • Palouse Capital Management first reported a position in Merck in Q1 2021 and held it in 6 quarters.
  • Palouse Capital Management's Merck position peaked at $3.24M in Q1 2022.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Palouse Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.